title: Orbital inflammation after zoledronate infusion: an emerging complication.
authors: Ehsan
authors: E
authors: Rahimy
authors: Simon K
authors: SK
authors: Law
mesh_terms: D000368:Aged; D001763:Blepharoptosis / Q000139:chemically induced; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D004487:Edema / Q000175:diagnosis; D005094:Exophthalmos / Q000139:chemically induced; D005141:Eyelid Diseases / Q000139:chemically induced; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007262:Infusions, Intravenous; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D054517:Orbital Cellulitis / Q000139:chemically induced* / Q000000981:diagnostic imaging / Q000188:drug therapy; D010024:Osteoporosis / Q000188:drug therapy; D014057:Tomography, X-Ray Computed; D000077211:Zoledronic Acid
chemical_list: D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D005938:Glucocorticoids; D007093:Imidazoles; D000077211:Zoledronic Acid; D008775:Methylprednisolone